- centralize management and announcements of opportunities and training events
- captures trainees' progress
- provide a webportal for the funders the H3Africa Education & Coordinated Training Working Group (ECTWG) to track progress and adapt the H3Africa training efforts based on evidence.
|17th H3Africa Consortium Meeting: Fellows Call for Abstracts||Monday, April 19, 2021 to Friday, April 23, 2021|
|17th H3Africa Consortium Meeting||Monday, April 19, 2021 to Friday, April 23, 2021|
|16th H3Africa Consortium Meeting: Fellows Call for Abstracts||Monday, September 7, 2020 to Friday, September 11, 2020|
|16th H3Africa Consortium Meeting||Monday, September 7, 2020 to Friday, September 11, 2020|
|15th H3Africa Consortium Meeting - Emara Ole Sereni, Nairobi, Kenya||Sunday, March 8, 2020 to Friday, March 13, 2020|
|Type||Title||Opening / Closing date|
|Maintenance||Maintenance Slot||Tuesday, November 10, 2020 - 10:45 to 12:00|
|Workshop||Successes and failures of grants writing||Tuesday, September 15, 2020 - 14:00 to 15:30|
|Distance learning||Ethics and Human Subject Protection: A Refresher Course||Wednesday, November 6, 2019 (All day)|
Spotlight - H3Africa Study Coordinator
Ms. Temilola Yusuf is a study coordinator for the H3Africa’s African Female Breast Cancer Epidemiology (AFBRECANE) Project (PI: Prof. Clement Adebamowo). A multi-site project in Nigeria, AFBRECANE is a case-cohort study of genomic and epidemiological risk factors of molecular subtypes of breast cancer in African women. It also explores new diagnostic, predictive and prognostic methods within the continuum of care of breast cancer patients.
Temilola holds a Bachelor’s degree and a Master’s degree in Pharmacology & Therapeutics from Olabisi Onabanjo University, Ago-Iwoye and University of Ibadan, Ibadan, Nigeria respectively. She has received extensive trainings and has vast hands-on experience in epidemiology, genomics, bioethics and qualitative studies. Her core areas of interest lie in pharmacoepidemiology and genomics of non-communicable diseases particularly cancer and malaria as well as ethical conduct of biomedical research.
She is presently a Research Associate at the Center for Bioethics and Research (CBR), Ibadan, Nigeria, where she is progressively building a career in Pharmacogenomics and Bioethics. Prior to AFBRECANE, she was part of the INDIGENE study team and coordinated the Moderate Alcohol and Cardiovascular Health (MACH15) Trial in Nigeria. You can reach Temilola via email@example.com; +234 806 165 1175.